335 filings
Page 7 of 17
424B5
vnxsk m8h4zw2bs9
14 Jun 17
Prospectus supplement for primary offering
12:00am
8-K
mthnjpq0gbg2d8buo6
13 Jun 17
Entry into a Material Definitive Agreement
12:00am
424B5
9d3107i9vc2
12 Jun 17
Prospectus supplement for primary offering
12:00am
8-K
mkcemad
12 Jun 17
GenMark Receives FDA 510(k) Market Clearance for its ePlex® Instrument and Respiratory Pathogen Panel
12:00am
8-K
kcfn f3peese0
6 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
ei34se73x2b3a
31 May 17
Submission of Matters to a Vote of Security Holders
12:00am
SD
7pjt8orzlz8lj3zso
31 May 17
Conflict minerals disclosure
12:00am
CT ORDER
iln1vfx
9 May 17
Confidential treatment order
12:00am
8-K
lth6i 6kaeq6ugz
2 May 17
GenMark Diagnostics Reports First Quarter 2017 Results
12:00am
8-K
g6ae4676vo1kzkz6zs65
20 Apr 17
GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Fungal Pathogen Panel
12:00am
DEFA14A
ca81axfkm 830sars
13 Apr 17
Additional proxy soliciting materials
12:00am
CT ORDER
oeic9yvs dt5pc7v
6 Mar 17
Confidential treatment order
12:00am
S-8
pe0h1wbg68nss mepr
1 Mar 17
Registration of securities for employees
12:00am
8-K
inw68b58230qng2aecjy
28 Feb 17
GenMark Diagnostics Reports Fourth Quarter and Full Year 2016 Results
12:00am
8-K
s1f5f0jcohsc41jr2r
24 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
344xnqmnsq5mc9g5ua2q
10 Jan 17
GenMark Announces Preliminary Q4 2016 Financial Results
12:00am
CT ORDER
mqbqod1
21 Nov 16
Confidential treatment order
12:00am